Pharma Mar, S.A.U.
Records under this name other than patents Pharma Mar, S.A.U. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Pharma Mar, S.A.U.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,507,708 | Antitumoral compounds Lapsed on the fee record Ended Mar 24, 2021 · From the USPTO record | Lapsed on the fee record | Ended Mar 24, 2021 | From the USPTO record |
| US 7,683,028 | Kahalalide compositions Lapsed on the fee record Ended Mar 23, 2018 · From the USPTO record | Lapsed on the fee record | Ended Mar 23, 2018 | From the USPTO record |
| US 7,622,458 | Combination of ET-743 and a 5-fluorouracil pro-drug for cancer treatment Lapsed on the fee record Ended Nov 24, 2017 · From the USPTO record | Lapsed on the fee record | Ended Nov 24, 2017 | From the USPTO record |
| US 7,576,188 | Antitumoral treatments Lapsed on the fee record Ended Aug 18, 2017 · From the USPTO record | Lapsed on the fee record | Ended Aug 18, 2017 | From the USPTO record |
| US 7,323,444 | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis Lapsed on the fee record Ended Jan 29, 2016 · From the USPTO record | Lapsed on the fee record | Ended Jan 29, 2016 | From the USPTO record |
| US 7,521,478 | Total synthesis of myriaporones Lapsed on the fee record Ended Apr 21, 2013 · From the USPTO record | Lapsed on the fee record | Ended Apr 21, 2013 | From the USPTO record |
| US 7,396,837 | Antitumoral analogs of lamellarins Lapsed on the fee record Ended Jul 8, 2012 · From the USPTO record | Lapsed on the fee record | Ended Jul 8, 2012 | From the USPTO record |
| US 7,309,601 | Sequences from an endosymbiont and their uses Lapsed on the fee record Ended Dec 18, 2011 · From the USPTO record | Lapsed on the fee record | Ended Dec 18, 2011 | From the USPTO record |